Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Stifel analyst James Condulis initiated coverage on Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) with a Buy rating and announced a price target of $21. Amylyx Pharmaceuticals shares closed at $15.30 on Monday. See how other analysts view this stock.
- Goldman Sachs analyst Leah Jordan initiated coverage on Once Upon A Farm PBC (NYSE:OFRM) with a Buy rating and announced a price target of $43. Once Upon a Farm shares closed at $23.58 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Judah Frommer initiated coverage on Agomab Therapeutics NV (NASDAQ:AGMB) with an Overweight rating and announced a price target of $28. AgomAb Therapeutics shares closed at $16.21 on Monday. See how other analysts view this stock.
- Stifel analyst Tom Stephan initiated coverage on SpyGlass Pharma, Inc. (NASDAQ:SGP) with a Buy rating and announced a price target of $42. SpyGlass Pharma shares closed at $26.73 on Monday. See how other analysts view this stock.
Considering buying AMLX stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments